Analysis | Metabolite Name | Measured Value | Units | subject type |
---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 2305 | Peak area | Severe disease |
Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 10789 | Peak area | Healthy control |
Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 12526 | Peak area | Severe disease |
Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 14602 | Peak area | Mild disease |
Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 20206 | Peak area | Mild disease |
Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 20244 | Peak area | Healthy control |
Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 27219 | Peak area | Healthy control |
Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 27847 | Peak area | Severe disease |
Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 33666 | Peak area | Severe disease |
Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 411232 | Peak area | Mild disease |
Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 422001 | Peak area | Mild disease |
Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | Peak area | Healthy control | |
Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | Peak area | Mild disease | |
Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | Peak area | Severe disease | |
Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 23581 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 25110 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 36544 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 39967 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 44108 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 44239 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 44917 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 46159 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 50577 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 55519 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 55684 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 67774 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 76093 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 76960 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 79476 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 194924 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 215079 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 235272 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 1195 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 3623 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 4096 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 6197 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 6626 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 8493 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 9272 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 9466 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 10286 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | Peak area | Healthy control | |
Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | Peak area | Mild disease | |
Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | Peak area | Severe disease |